Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 2,311 | 1,034 | 470 | 321 | 515 |
| Cost of Goods | 741 | 841 | 339 | 812 | 265 |
| Gross Profit | 1,570 | 193 | 131 | -491 | 250 |
| Operating Expenses | 2,827 | 3,183 | 2,704 | 3,800 | 7,035 |
| Operating Income | -516 | -2,149 | -2,234 | -3,479 | -6,520 |
| Other Income | 180 | 153 | 136 | -24 | -1,350 |
| Pre-tax Income | -337 | -1,996 | -2,098 | -3,503 | -7,870 |
| Income Tax | 8 | 2 | -3 | 7 | N/A |
| Net Income Continuous | -344 | -1,998 | -2,095 | -3,510 | -7,870 |
| Net Income | $-338 | $-1,998 | $-2,101 | $-3,510 | $-7,870 |
| EPS Basic Total Ops | 46.40 | -12.00 | -18.20 | -81.20 | -262.60 |
| EPS Basic Continuous Ops | 46.35 | -12.01 | -18.21 | -81.07 | -262.33 |
| EPS Diluted Total Ops | 46.40 | -12.00 | -18.20 | -81.20 | -262.60 |
| EPS Diluted Continuous Ops | 46.35 | -12.01 | -18.21 | -81.07 | -262.33 |
| EBITDA(a) | $-463 | $-2,099 | $-2,185 | $-3,430 | $-6,466 |